Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for Dr Reddys Laboratories (RDY) over the last 14 years, with Q4 2025 value amounting to -$427.0 million.

  • Dr Reddys Laboratories' Total Non-Current Liabilities changed N/A to -$427.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$427.0 million, marking a year-over-year change of. This contributed to the annual value of $298.0 million for FY2025, which is 12575.76% up from last year.
  • Dr Reddys Laboratories' Total Non-Current Liabilities amounted to -$427.0 million in Q4 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Total Non-Current Liabilities peaked at $332.4 million during Q3 2025, and registered a low of -$427.0 million during Q4 2025.
  • Its 5-year average for Total Non-Current Liabilities is -$8.9 million, with a median of $85.6 million in 2022.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Total Non-Current Liabilities tumbled by 10053907315.89% in 2023, and later soared by 17700.64% in 2024.
  • Over the past 5 years, Dr Reddys Laboratories' Total Non-Current Liabilities (Quarter) stood at -$325.0 million in 2021, then dropped by 6.0% to -$344.5 million in 2022, then soared by 134.25% to $118.0 million in 2023, then soared by 177.01% to $326.8 million in 2024, then plummeted by 230.66% to -$427.0 million in 2025.
  • Its last three reported values are -$427.0 million in Q4 2025, $332.4 million for Q3 2025, and $293.7 million during Q1 2025.